Development of a highly sensitive diagnostic assay for muscle-specific tyrosine kinase (MuSK) autoantibodies in myasthenia gravis

Journal of Neuroimmunology

Volumn 240-241, Issue , 2011, Pages 79-86

  Trakas, Nikolaos ^a,b   Zisimopoulou, Paraskevi ^a   Tzartos, Socrates J ^a,b  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Diagnosis; Extracellular domains; MuSK autoantibodies; Myasthenia gravis; RIPA

Indexed keywords

AUTOANTIBODY; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; ESCHERICHIA COLI; HUMAN; INTERMETHOD COMPARISON; MYASTHENIA GRAVIS; NONHUMAN; PICHIA PASTORIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; AUTOANTIGENS; GLYCOSYLATION; HUMANS; MYASTHENIA GRAVIS; RADIOIMMUNOPRECIPITATION ASSAY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; SENSITIVITY AND SPECIFICITY;

EID: 83555177308     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2011.09.007     Document Type: Article

References (23)

1. Bartoccioni E., Scuderi F., Minicuci G.M., Marino M., Ciaraffa F., Evoli A. Anti-MuSK antibodies: correlation with myasthenia gravis severity. Neurology 2006, 67:505-507.
2. Cole R.N., Reddel S.W., Gervasio O.L., Phillips W.D. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction. Ann. Neurol. 2008, 63:782-789.
3. Conti-Fine B.M., Milani M., Kaminski H.J. Myasthenia gravis: past, present, and future. J. Clin. Invest. 2006, 116:2843-2854.
4. DeChiara T.M., Bowen D.C., Valenzuela D.M., Simmons M.V., Poueymirou W.T., Thomas S., Kinetz E., Compton D.L., Rojas E., Park J.S., Smith C., DiStefano P.S., Glass D.J., Burden S.J., Yancopoulos G.D. The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 1996, 85:501-512.
5. Greenwood F.C., Hunter W.M., Glover J.S. The preparation of I-131-labelled human growth hormone of high specific radioactivity. Biochem. J. 1963, 89:114-123.
6. Hewer R., Matthews I., Chen S., McGrath V., Evans M., Roberts E., Nute S., Sanders J., Furmaniak J., Smith B.R. A sensitive non-isotopic assay for acetylcholine receptor autoantibodies. Clin. Chim. Acta 2006, 364:159-166.
7. Hoch W., McConville J., Helms S., Newsom-Davis J., Melms A., Vincent A. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 2001, 7:365-368.
8. Kostelidou K., Trakas N., Tzartos S.J. Extracellular domains of the beta, gamma and epsilon subunits of the human acetylcholine receptor as immunoadsorbents for myasthenic autoantibodies: a combination of immunoadsorbents results in increased efficiency. J. Neuroimmunol. 2007, 190:44-52.
9. Leite M.I., Strobel P., Jones M., Micklem K., Moritz R., Gold R., Niks E.H., Berrih-Aknin S., Scaravilli F., Canelhas A., Marx A., Newsom-Davis J., Willcox N., Vincent A. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann. Neurol. 2005, 57:444-448.
10. Leite M.I., Jacob S., Viegas S., Cossins J., Clover L., Morgan B.P., Beeson D., Willcox N., Vincent A. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008, 131:1940-1952.
11. Matthews I., Chen S., Hewer R., McGrath V., Furmaniak J., Rees Smith B. Muscle-specific receptor tyrosine kinase autoantibodies-a new immunoprecipitation assay. Clin. Chim. Acta 2004, 348:95-99.
12. McConville J., Farrugia M.E., Beeson D., Kishore U., Metcalfe R., Newsom-Davis J., Vincent A. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann. Neurol. 2004, 55:580-584.
13. Meriggioli M.N., Sanders D.B. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009, 8:475-490.
14. Oh S.J. Muscle-specific receptor tyrosine kinase antibody positive myasthenia gravis current status. J. Clin. Neurol. 2009, 5:53-64.
15. Shigemoto K., Kubo S., Maruyama N., Hato N., Yamada H., Jie C., Kobayashi N., Mominoki K., Abe Y., Ueda N., Matsuda S. Induction of myasthenia by immunization against muscle-specific kinase. J. Clin. Invest. 2006, 116:1016-1024.
16. Shiraishi H., Motomura M., Yoshimura T., Fukudome T., Fukuda T., Nakao Y., Tsujihata M., Vincent A., Eguchi K. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Ann. Neurol. 2005, 57:289-293.
17. Stack C.M., Dalton J.P., Cunneen M., Donnelly S. De-glycosylation of Pichia pastoris-produced Schistosoma mansoni cathepsin B eliminates non-specific reactivity with IgG in normal human serum. J. Immunol. Methods 2005, 304:151-157.
18. Stiegler A.L., Burden S.J., Hubbard S.R. Crystal structure of the agrin-responsive immunoglobulin-like domains 1 and 2 of the receptor tyrosine kinase MuSK. J. Mol. Biol. 2006, 364:424-433.
19. Tsiamalos P., Kordas G., Kokla A., Poulas K., Tzartos S.J. Epidemiological and immunological profile of muscle-specific kinase myasthenia gravis in Greece. Eur. J. Neurol. 2009, 16:925-930.
20. Valenzuela D.M., Stitt T.N., DiStefano P.S., Rojas E., Mattsson K., Compton D.L., Nunez L., Park J.S., Stark J.L., Gies D.R., et al. Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 1995, 15:573-584.
21. Vincent A., Willcox N., Hill M., Curnow J., MacLennan C., Beeson D. Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis. Immunol. Rev. 1998, 164:157-168.
22. Zisimopoulou P., Lagoumintzis G., Kostelidou K., Bitzopoulou K., Kordas G., Trakas N., Poulas K., Tzartos S.J. Towards antigen-specific apheresis of pathogenic autoantibodies as a further step in the treatment of myasthenia gravis by plasmapheresis. J. Neuroimmunol. 2008, 201-202:95-103.
23. Zisimopoulou P., Lagoumintzis G., Poulas K., Tzartos S.J. Antigen-specific apheresis of human anti-acetylcholine receptor autoantibodies from myasthenia gravis patients' sera using Escherichia coli-expressed receptor domains. J. Neuroimmunol. 2008, 200:133-141.